Avidity Biosciences Inc. (NASDAQ:RNA)
To request coverage of this stock, please click the green request video box on the right.
Old Forum Content for RNA
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.- wwhite70: $RNA Alert on move above long base. Looks like a good setup even though up over 10% today. Still hesitant to take the trade this morning. What do you think?
- gswwired: $RNA Breaking out
- Crodmm: $RNA Nice move, HOD. Can’t find any news. Long.
-
StockMarketMentor: ...
On Tuesday, 50,000 members of the International Longshoremen’s Association (ILA), the largest longshoremen’s union in North America, went on strike at 14 major ports along the Gulf of Mexico and Eastern Seaboard, affecting billions of do ... -
StockMarketMentor: ...
$RNA is stopped out.
$WING will likely get stopped out this morning, though 370 might hold. Our stop is at 369.95, so we haven't given the logical $370 support much room. Nevertheless, I'm sticking with it because I don't want to risk losing mo ... - woodman: $RNA - out of this.
-
StockMarketMentor: ...
Viking Therapeutics ($VKTX) is working ok, and $GE is pushing up against resistance and still strong. $RNA continues to hold the 50dma and looks like it's going to hold at that level. The trading has been on pretty light volume, which indicates a ... - Crodmm: $RNA Looks good coming out of a squeeze and above all the MA’s. Long
- woodman: @Crodmm $RNA - Long as well, but it's still within consolidation, essentially right in the middle of it as it is just atop the 20dSMA. The high of this consolidation is $48.80 (7/29 intraday high) and the top BB is ~$47.00, where as current price is $44.93. But I still like the set up with the BBs tighter than they've been in quite some time.
- Crodmm: @woodman $RNA you are correct. I was concentrating more of the tighter price action of the last 2 weeks. Squeezes are my favorite set up, so always looking for them.
-
StockMarketMentor: ...
I mentioned the possibility of adding $RNA to the ATI List if it holds up this morning. That's definitely on the table, though I want to watch how it opens. It's up about 2.25% this morning,...but we're talking about 6,800 shares. So, for all I k ... - traderbren: $RNA - back above the 8ema and 20d -- could be primed for a move higher...
- woodman: @traderbren $RNA - the BBs are about as tight as I've seen them over the past 2 years.
- woodman: @StockMarketMentor $XLF $SMH $NVDA - I'm in and holding $RNA.
- woodman: $RNA - is a little wobbly here, but I note it's at a triple support area: (1) the 50d; (2) rising support from the day it gapped-up on 6/12/24; (3) long term rising support from its true bottom on 10/27/2023. It's also in blue sky post-gap-up, having moved above its prior ATH (back in Sept. 2020) on that 6/12 gap up. No position currently. (Full disclosure - I have not researched this biotech; I'm just looking at the chart.)
- Crodmm: @woodman $RNA Down today due to announcing a secondary. I have a small position. Considering an add if it stabilizes here.
- woodman: @Crodmm $RNA - Thanks.
- woodman: $RNA - I bought after posting earlier today, and added a little more here in the home stretch.
- Crodmm: @woodman $RNA me too
- Crodmm: @woodman $RNA. any thoughts on this biotech. Up on earnings this A.M.
- woodman: @Crodmm $RNA - I've traded it, but haven't done a deep dive into knowing its story.
- Bridgemate: $RNA at the 8day, breaking out again?
-
StockMarketMentor: ...
Several of the stocks I covered over the weekend as a part of my Fitz Watch List are working well today. See $KKR $APP $RNA $APPF and $NTRA (thin, but looking like it really wants to move with $115 as resistance).
I will be opening up the traini ... - jeffrhen55: @StockMarketMentor $ARKK $FFTY $IYT $XPO $JBLU $XOP $XLE $KKR $APP $RNA $APPF $NTRA Well stated! Thanks Dan.
- bigreek42: $rna bullish engulfing
- bigreek42: watching $rna
- mogo: $RNA 8 day SMA looks like good support and not too far below for a stop.
- Bridgemate: $RNA. Good news!
- woodman: @Bridgemate $RNA - WooHoo. I have a decent position in my trading account.
- woodman: @Bridgemate $RNA https://aviditybiosciences.investorroom.com/2024-06-12-Avidity-Announces-Unprecedented-AOC-1020-Data-from-Phase-1-2-FORTITUDE-TM-Trial-Demonstrating-Greater-Than-50-Percent-Reduction-in-DUX4-Regulated-Genes-and-Trends-of-Functional-Improvement-in-People-Living-with-Facioscapulohumeral-Muscular-Dyst
- Cjauger: @woodman $RNA congratulations
- Bridgemate: @woodman $RNA Yes! THANK YOU!
- woodman: @Cjauger $RNA - Thank you! On days like today, I like to conveniently forget my losers.
- StockMarketMentor: $RNA is still forming the bottom of a base around the 50-day moving average and looks promising. I set an alert last week at 27.66 to remind me about the stock. The pivot point on the stock is 28.83 (From 6/5). So, I can't assume that the stock will have a lot of upside from here. It's more a case of believing that the stock is finding new support at the 50-day moving average. I think it's a bit early to be starting a position, and I will be off the grid for a few days due to a scheduled knee surgery tomorrow so I can't watch the stock until next week. Just wanted to mention it. --Dan
- wineinquirer: @StockMarketMentor $RNA Be thinkin' of you, Dan..........Your positive outlook on "life" will get you through!!
- DAN: @wineinquirer $RNA Thanks wineinquirer. Gotta keep a PMA, though it is sometimes challenging when I seem to have one surgery after another. (Back surgery coming up later this year.) Jeez, I've got the body of a veteran NFL player...but never got the glory or the money. Life just ain't fair!! 0-)
- marklesparkle: @StockMarketMentor $RNA Dan I wish you the best recovery and the guys I know that had knee work bounced back quick and better and they were old too LMAO you know what I mean. We Love You Dan
- bwcarnation1: @DAN $RNA wishing you the best and a speedy recovery.
- DAN: @bwcarnation1 $RNA Thanks, bwcarnation1. I appreciate it. I'm sure that I'll bounce back...I'm just not as young as I used to be, and the bounces aren't quite as quick. ;-)
- wineinquirer: @DAN $RNA Last 10y: multi-lvl lumbar, cervical C5-6, L hip, R hip, L biceps tear, & what I hope is the final insult recently, extraction of 5 infected cardiac defib leads & the device itself with a new one implanted and tricuspid valve repair, I'm 73 and after 18d hospitalized, severe anemia &10lbs wt loss, I'm fully back swimming/walking a few miles daily after 3 months home based PT due to my ocd/type A, retired doc personality!!! If I can do it, I know you can, as well. You've clearly lived life hard but it has steeled you for the challenges ahead.
- gmj: @StockMarketMentor $RNA Best to you going into surgery, prayers for successful surgery and recovery.
- woodman: $RNA - decent day today. This has been consolidating. The BBs have been coming in - "squeezing" (relatively speaking) - at the 50d.
- DAN: @marklesparkle $RNA Thanks Mark! Love you right back, brother!
- woodman: $RNA - interesting.
- woodman: $RNA - keep an eye on this.
- woodman: $RNA rising off the 50d after falling back to it within prior consolidation following a breakout.
-
StockMarketMentor: ...
I will be closing down several of the ATI stocks because I just don't like the risk. If it's a losing position (and now I see losses in $COIN $WFC $RNA $AMZN $AMAT $LLY), they are done! Off the list. Others I will take one at a time.
Check the ... - marklesparkle: @StockMarketMentor $SPY $QQQ $COIN $WFC $RNA $AMZN $AMAT $LLY Go on take the money and run
- StockMarketMentor: Closed down $MU -- double top $COIN -- an early speculative buy did not pan out. Take the loss and move on. $RNA -- closing down. It never really took off like I had hoped. $WFC -- stop hig $AMZN -- break of 50-day MA $AMAT -- gap and reverse. Take the small loss. $BKNG -- Bad booking here. Giving the keys back. $MSTR -- test of 1750 failed. This has a lot more work to do from here. $IBIT -- Down, but not out. This could have gone either way. But I’m just taking it off for a b/e trade. $MS -- I don’t like the way this is acting. $GOOGL -- Rolling over and down below the 4/26 high. $PSTG -- gap and reverse $GS -- Rolling out of the channel. --Dan
- curtis: @StockMarketMentor $MU $COIN $RNA $WFC $AMZN $AMAT $BKNG $MSTR $IBIT $MS $GOOGL $PSTG $GS (Thanks)
- Simar297: @StockMarketMentor $MU $COIN $RNA $WFC $AMZN $AMAT $BKNG $MSTR $IBIT $MS $GOOGL $PSTG $GS are we closing $lly as well Dan, please advise
- ManSim: @StockMarketMentor $MU $COIN $RNA $WFC $AMZN $AMAT $BKNG $MSTR $IBIT $MS $GOOGL $PSTG $GS Hi Dan I jsut want to confirm that you just took $MSFT off the ATL? Should $LLY be off as well? Thank you.
- woodman: $RNA was a nice call by the SMM powers - @Dan @Scottrades. I bought right after it was posted. The breakout continues today. Let's see if it gets through 30.54 high of last week.
-
StockMarketMentor: ...
$RNA -- Phase 2 pullback. The current risk on the trade is around 7.6%. I try to trade a bit tighter than that and I would suggest looking at your trade and deciding whether that risk (in dollar terms) is acceptable. If not, you know what to do T ... - marklesparkle: @StockMarketMentor $SMH $AMD $MSFT $RNA $CRWD $MU $RCL Thanks Dan Wish you well on the knee early and one more thing. Militating????
- Geewhiz: @marklesparkle $SMH $AMD $MSFT $RNA $CRWD $MU $RCL influence, effect , be a deciding factor. He was a lawyer.
- debeers: @StockMarketMentor $SMH $AMD $MSFT $RNA $CRWD $MU $RCL -Good luck with the Knee. We "kneed" ya but take your time healing
-
StockMarketMentor: ...
$RNA -- Up another 2% today. Raising the suggested stop on this new addition from 24.20 to 26.35 (just below yesterday's high volume move that attracted me to this stock.)
$WFC -- Just getting going. No change here.
$JPM -- No change here. ... - HowardIII: @StockMarketMentor $DELL $BPMC $GS $CRWD $PSTG $GOOGL $NVDA $AMZN $KKR $AVGO $BKNG $MSFT $RNA $WFC $JPM $BAC $MU Dan.. what's your interpretation for the banks catching a bid as of late? Charts looks great..
- woodman: @StockMarketMentor $DELL $BPMC $GS $CRWD $PSTG $GOOGL $NVDA $AMZN $KKR $AVGO $BKNG $MSFT $RNA $WFC $JPM $BAC $MU - KKR is a breakout. Looks nice on the weekly in terms of making the next leg up.
- Onthemark: $RNA new high
- woodman: @Onthemark $RNA - nice breakout. Good call by the SMM powers - @Dan/@Scottrades. I bought yesterday on their call-out.
- StockMarketMentor: Adding $AVGO and $RNA to the Active Trade Ideas list. AVGO -- Basis 1376.62 Stop 1274.90 RNA -- Basis 28.50 Stop 24.20 Dan
- geotheo: @StockMarketMentor $AVGO $RNA Like the new charts when you hover over the stock symbols.
- woodman: @StockMarketMentor $AVGO $RNA - $RNA looks good. Also recently had news: https://aviditybiosciences.investorroom.com/2024-05-08-Avidity-Biosciences-Receives-FDA-Breakthrough-Therapy-Designation-for-Delpacibart-Etedesiran-AOC-1001-for-Treatment-of-Myotonic-Dystrophy-Type-1 And other news in the therapeutic area may also be giving it a boost. https://www.biopharmadive.com/news/sanofi-fulcrum-muscular-dystrophy-drug-deal/715893/ In any event, it's a nice breakout here.
- JosephM: @StockMarketMentor $AVGO $RNA 15% stop on RNA?
- Onthemark: @JosephM $AVGO $RNA For me, calls for a small starter and then add on the way up.
- scottrades: My notes: $SPY Priced for Perfection $QQQ Back to the scene of the crime $IWM Watch 208 $DXY Watch tomorrow $TNX Watch tomorrow $GLD Watch tomorrow $SLV Watch tomorrow $GDX Watch tomorrow $SMH Watch 231 $XLF Watch 42.20 $XLK Watch 212 $GBTC Weekly Handle $AMZN Support at the 21 EMA $MSFT Watch above 418 $NVDA Earnings May 22 $AAPL Extended off the 8EMA $GOOGL Had their IO Event today $DELL Working $META Watch 477.50 $MU Curling up $AXP Working $CRWD Added to The ATL @ 325.13 - Stop 307.50 $PSTG ATL @ 55.89 - Stop 52.25 $AVGO ATL @ 1376.62 - Stop 1274.90 $RNA ATL @ 28.50 - Stop 24.20 $MSTR Coiled under the 50 Day
- TRICIA: $RNA #RNAI tickers ... http://elite.finviz.com/screener.ashx?v=211&t=ROSG,ALNY,ARWR,DRNA,MRNA,TKMR,RXII,SLN-L,BLT-AX,ISIS,RGLS,RSGN,SRPT,RNA,RGDO,PTCT,RNA,BLUE&o=-change you can quickly flip to see year performance ..."Custom" Some group movement due to Prosena acquisition ... who is next ... maybe $TKMR by one of the big guys vying for HEP B ...$ARWR ??? I am an surprised $SRPT isup .. Chris G CEOis an idiot ... but the chart todya says otherwise ... no position in SRPT
- Alltradepros9: any news on Prosensa $RNA and DMD trials this seems to have catalyst to up side
- Tricia: #BIOTECH EArnings week - 44 This Week! EArnings Mon 08/11 incl: $MACK $INO $AKBA $BLUE $RYLP $ENTA $PBYI $HALO (26 Today) Earnings Tues 08/12 incl: $INSY $BCRX $ARRY $RNA $PETX $STEM $ARWR (13) Earnings Wed 08/13 incl: $EPZM $CNAT $ONTX $TKMR There is a lot of data this week also .. should be very interesting $EPZM data at ASH Lymphoma meeting on August 12 $OPK will have top-line Rayaldee data on Monday night as well. Hep B Updates from $ARWR, $TKMR -- $ALNY will have another roundtable with $MDCO
-
howardbd: ...
managment - internal strife with senior management, 2 CSO's have been let go over the last 2 years
The company has very little progress to show over the last 2 years (except the phase 2 clinical), most likely due to the FDA slow getting on board wit ... - stocky: $RNA Looks like a gap wanting to fill $LOCK On the way back? $MPEL Off 200 day av. after pullback Thanks for comments last week regarding $GA squeeze
- Tricia: RNAi therapies continue to recover from last Friday...as I posted first thing Monday, Fridays' patent bullying from from $ALNY was a big buy opp .. $TKMR, $ARWR, $RNA, and even that penny ticker $MRNA ..
- dmgrevas: $RNA - First day of phase 3. In at 10.50
- gwenzee: $SRPT-Made $$ and lost $$ on this stock. Should have gotten back in at $31 or so but chickened out. Europe gave conditional approval to $PTCT for its DMD drug. $RNA up in sympathy as well as $SRPT. Has gotten some upgrades lately, bought a manufacturing facility, lots of pressure on FDA for approval, etc. What's not to like?
- scottto: $TKMR - It was a matter of time: "Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of $RNA interference (RNAi) therapeutics, today announced that it is offering to sell shares of its common stock in an underwritten public offering to raise gross proceeds of approximately US$60 million. Tekmira also expects to grant the underwriters a 30-day option to purchase additional shares of its common stock offered in the public offering to cover over-allotments, if any. All of the shares in the offering are to be sold by Tekmira, with net proceeds to be used to develop and advance product candidates through clinical trials, as well as for working capital and general corporate purposes. "
- career2: $TKMR So even though the word "Earnings" wasn't used, its TKMR's earning's day: "Tekmira Pharmaceuticals Corporation (TKMR) (TKM.TO), a leading developer of $RNA interference (RNAi) therapeutics, announced that it will hold a conference call and webcast on Thursday, March 6, 2014 at 1:30 pm Pacific Time (4:30 pm Eastern Time) to provide a corporate update and report 2013 year-end financial results." So the stock is up "big", again just like any other earnings... should one hold through earnings? Especially in light of the stock rocketing up today... ie. take the profit now, or use what seems like the SMM strategy right now, of taking some profits and hold a "bit" through earnings ( a bit being if the stock drops 15%, it won't bother you... much).
- career2: $TKMR From Wall Street Cheat Sheet: A third winner during Wednesday's trading session is Tekmira Pharmaceuticals. Tekmira Pharmaceuticals is a leader in the development of therapeutic agents based upon Nobel Prize-winning breakthroughs in the field of gene silencing, known as $RNA interference (RNAi). The company's pipeline is targeting cancer, Ebola infection, and other indications. Shares of Tekmira are rallying by more than 23 percent in Wednesday's trading session. The company is likely rallying in sympathy with Arrowhead Research as analysts, investors, and investment firms begin to understand the potential impact of RNAi-based drug candidates. One of the interesting things to note is that Tekmira carries a market capitalization much lower than that of Arrowhead. If $RNA therapeutics are indeed the future, Tekmira could be in store for a big run.
- Poppy: Great weekend read in investing in biotech with specific names like $SRPT PTCT $RNA DSCI $AMPE http://seekingalpha.com/article/2058403-evaluate-biotech-stocks-with-cynicism-debjit-chattopadhyay?source=email_authors_alerts&ifp=0
- Esslinger: $TKMR - Feb. 25, 2014 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of $RNA therapeutics, announced that recent advances in the enablement of messenger $RNA (mRNA) using Tekmira's lipid nanoparti ...
-
Tricia: $BLT ASX) Benitec Biopharma: MORE RNAi therapy that Targets Hep $C and Hep $B ...get $31Mil from American Investors ....
Benitec Biopharma is investigating long term gene silencing using DNA-directed $RNA interference (ddRNAi) for human therap ... - career2: $TKMR VANCOUVER, British Columbia, Feb. 21, 2014 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (TKMR) (TKM.TO), a developer of $RNA interference (RNAi) therapeutics, today announced that it has filed a preliminary short form base shelf prospectus with securities regulatory authorities in Canada, other than Quebec, and a corresponding shelf registration statement with the United States Securities and Exchange Commission (the "SEC") on Form F-10. Once the shelf prospectus is cleared and the shelf registration statement becomes effective, these filings will, subject to securities regulatory requirements, provide for the potential offering in Canada and the United States of up to an aggregate of US$150 million of Tekmira's common shares, warrants to purchase common shares and/or units comprising any combination of the foregoing from time to time over a 25-month period after Canadian securities regulatory authorities have issued a receipt for the final short form base shelf prospectus.
-
SierraJW: ...
Marburg hemorrhagic fever is a severe and potentially fatal disease in humans first recognized in 1967. It is caused by an $RNA virus of the Filoviridae family and is understood to be endemic to Africa. The Marburg virus is classified as a Category ... - woodman: $TKMR - another @Tricia $RNA stock, looking frisky.
-
Esslinger: ...
VANCOUVER, British Columbia, Jan. 14, 2014 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of $RNA interference (RNAi) therapeutics, today announced that it has dosed the first subject in a Phase ... - tnt: $SRPT 1/3 of float sold short and now below the levels at which $RNA their only competitor blew up. I am long now a full position in $SRPT
- tnt: $SRPT thanks @woodman and @slowtime, yes I saw the $SA article, seems like an opportunity to get in. $RNA now eliminated as a competitor, so gives $SRPT space and time to do it right
-
Tricia: ...
Today in Germany Tekmira presented ---Tekmira Demonstrates That mRNA is Efficiently Delivered Using its LNP.http://finance.yahoo.com/news/preclinical-data-presented-scientific-symposium-120000855.html ? This company is moved to the forefront becau ... - tnt: @woodman, yes now $SRPT the new leader in $DMD treatment with the failure of $RNA, nice discount here off the recent highs. I am not 100% convinced their treatment will be as successful as all hope, but then again who is ever 100% certain about anything especially biotech. Risk reward seems reasonable here
- Tricia: $RNA - buy trash, you get trash ... lol Deerfield buys 42% of Prosensa float, shares jump Shares of Prosensa (RNA +8.2%) spike after Deerfield Management discloses it has taken a 3.22M share position in the company, representing 42.5% of the float and 11.1% of shares outstanding. (SC 13G)As of Sept. 13, 1M shares had been sold short, nearly triple the interest on Aug. 30.
- beby138: $RNA - Hope nobody here got caught on this .
- Tricia: $BCRX : fades after great news and PM up of 6.6% .... I don't understand the fade... it actually turned red... I am still long but bewildered... Hre is this am's news: BioCryst gets NIAID contract for BCX4430 BioCryst (BCRX) scores a contract with the National Institute of Allergy and Infectious Diseases for the development of BCX4430, the company's $RNA dependent-RNA polymerase inhibitor for the treatment of Marburg virus. The goals are for $BCRX to file INDs for both an intravenous and intramuscular version and for the company to conduct a Phase 1 clinical trial.BCRX gets $5M upfront and is eligible to receive up to $22M total over five years. (PR)Shares +6.6% premarketBack in July, the company announced that the Biomedical Advanced Research and Development Authority had released funding for the completion of an NDA for peramivir, under a $234.8M contract with BCRX.
- dkoran: RNA- Trica- buddy of mine in the pharma business told me to keep an eye on RNA. $GSK and $RNA have some data coming due soon. Your thougts ?
-
nb8702: ...
Consolidated revenues more than doubled to $23.8 million during the three months ended June 30, 2013 , from $10.2 million in the prior year period and nearly tripled to $55.2 million for the six months ended June 30, 2013 , from $19.0 million in ... - reming: ALNY- Wanted to put this one out to be added to biotech types' radar screens. They are the first company to start the translation of miRNAs (micro $RNA technology) from the bench to real world therapy. They are engaged in some Phase I and II clinical trials. This area of research has moved at an astounding pace. For further info, check out their website: http://www.alnylam.com/
- reming: Life Technologies-FYI I am very familiar with this biotech company. I buy their products frequently. They supply all manner of supplies for biolgical research. They sell to other biotech companies and other biologic research facilities both government, private and university campuses. The recently joined forces with Applied Biosystems which is one of the largest suppliers of machine and supplies for the study of $RNA and DNA for PCR. Life Technologies doesn't have the risk other biotech companies have which generate drugs. This company is to many other biotech companies what chip makers are to Apple, Dell, $HPQ etc. Life Technologies has much competition but it is definitely one of the leaders.
-
Brick: ...
At Morningstar, we've seen various themes to these drug stock take-outs over the past year. In some cases, the larger firm in a collaboration takes out the smaller partner, in an effort to claim full rights to future profits; Amgen's $AMGN acquisi ...
Stock Price | $29.16 |
Change | -4.49% |
Volume | 1,828,800 |
Prosensa Holding N.V. is engaged in the discovery and development of RNA-modulating therapeutics for the treatment of rare genetic disorders. Its product candidates includes drisapersen and PRO044.
Request Video of RNAAlready a member? Sign in here.
Past Month
Leading Peers
-
$7.39 360.96%
-
$9.90 159.94%
-
$8.49 47.12%
Past Month
Lagging Peers
-
$5.52 -107.54%
-
$23.06 -71.52%
-
$7.21 -44.04%

Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.

Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!